Date ▲ Holder Code Drug Date from Subject 26.4.2022 Mylan IRE Healthcare Limited (MYR) 62402 Fraxiparine 7 600 IU (anti Xa)/0,8 ml (sol inj 10x0,8 ml/7,6 KU (striek.inj.skl.napl.)) 2.5.2022 O 26.4.2022 Mylan IRE Healthcare Limited (MYR) 96970 Fraxiparine 2 850 IU (anti Xa)/0,3 ml (sol inj 10x0,3 ml/2,85 KU (striek.inj.skl.napl.)) 2.5.2022 R 26.4.2022 Mylan IRE Healthcare Limited (MYR) 96986 Fraxiparine 5 700 IU (anti Xa)/0,6 ml (sol inj 10x0,6 ml/5,7 KU (striek.inj.skl.napl.)) 28.4.2022 O 25.4.2022 Fresenius Kabi Deutschland GmbH (FRK-1) 72170 NEPHROTECT (sol inf 1x500 ml (fľ.skl.)) 28.2.2022 R 25.4.2022 B.Braun Melsungen AG (BME) 8133A Amiped (sol inf 12x250 ml (vak.PP/styrén-etylén-butylén-styrén (SEBS)/polyéter-ester)) 25.4.2022 R 22.4.2022 Teva B.V. (TEV-NL-4) 4799C PLEUMOLYSIN (gto por 1x10 ml (fľ.skl.hnedá s bezpeč.uzáver.)) 16.5.2022 R 22.4.2022 Teva Czech Industries s.r.o. (TEV-CZ-2) 95234 Nasofan 50 mikrogramov nosový suspenzný sprej (aer nau 1x120 dávok (fľ.skl.)) 27.4.2022 R 22.4.2022 Genzyme Europe B.V. (GZE-1) 79106 Mozobil 20 mg/ml injekčný roztok (sol inj 1x1,2 ml/24 mg ( liek.inj.skl.)) 25.4.2022 R 22.4.2022 BAUSCH HEALTH IRELAND LIMITED (BAU-3) 42080 SUPRELIP (cps dur 30x200 mg (blis. PVC/Al)) 21.4.2022 O 22.4.2022 Egis Pharmaceuticals PLC (EGI) 6891B Rasagiline Egis 1 mg tablety (tbl 30x1 mg (blis.Al/Al)) 29.4.2022 R 22.4.2022 Teva B.V. (TEV-NL-4) 52120 Olfen 140 mg (emp med 10x140 mg (vre.papier/PE/Al/kopol.etylénmetakryl. kys.)) 29.4.2022 O 21.4.2022 Teva B.V. (TEV-NL-4) 2280D Ezetimib/simvastatín Teva B.V. 10 mg/40 mg (tbl 98x10 mg/40 mg (blis.OPA/Al/PVC/Al)) 15.6.2022 Z 21.4.2022 B.Braun Melsungen AG (BME) 80553 Braunol (sol der 1x1000 ml (fľ.PE)) 21.4.2022 R 21.4.2022 Actavis Group PTC ehf. (ACT-5) 85279 Sildenafil Actavis 100 mg filmom obalené tablety (tbl flm 8x100 mg (blis.PVC/PVDC/Al)) 15.5.2022 R 21.4.2022 TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK) 21309 Atorvastatin Teva Pharma 80 mg (tbl flm 90x80 mg (blis.Al/Al)) 29.4.2022 O
